FDA Inspection 785278 — Daniel A Long, MD
The FDA completed an inspection of Daniel A Long, MD on May 3, 2012 in Gretna, LA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 3, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gretna, LA (United States)
Additional Details
Clinical Investigator (CI)